AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Apr 28, 2010
34023_dirs_2010-04-28_e21a120a-063f-47d6-b98a-0032936281c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-04-26
Reporting Person: KLASKIN CHRISTINE M (VP, Finance)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-26 | Common Stock | A | 2500 | $1.19 | Acquired | 71988 | Direct |
| 2010-04-26 | Common Stock | S | 2500 | $1.2132 | Disposed | 69488 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 195 | Indirect |
Footnotes
F1: Represents settlement of restricted stock awarded on January 26, 2010.
F2: Represents the sale of shares obtained from the vesting of the restricted stock awarded on January 26, 2010. This sale has been made through a Rule 10b5-1 trading plan.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23